HighTower Advisors LLC Has $338,000 Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

HighTower Advisors LLC lowered its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 14.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,537 shares of the company’s stock after selling 3,139 shares during the period. HighTower Advisors LLC’s holdings in Privia Health Group were worth $338,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new stake in Privia Health Group in the 2nd quarter valued at about $26,000. GAMMA Investing LLC boosted its stake in shares of Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares during the period. Nisa Investment Advisors LLC boosted its stake in shares of Privia Health Group by 107.5% in the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after buying an additional 930 shares during the period. Signaturefd LLC grew its position in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after buying an additional 626 shares in the last quarter. Finally, KBC Group NV increased its stake in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after acquiring an additional 871 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Stock Down 0.3 %

Shares of PRVA stock opened at $20.07 on Monday. The firm has a market capitalization of $2.41 billion, a P/E ratio of 200.72, a P/E/G ratio of 5.45 and a beta of 0.83. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $24.30. The stock’s fifty day simple moving average is $20.30 and its 200 day simple moving average is $19.14.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Barclays upped their target price on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. KeyCorp began coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective for the company. Robert W. Baird raised their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Finally, Truist Financial lifted their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $24.80.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.